Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Summa Equity Acquires Proteomics Firm Sengenics

Summa Equity Acquires Proteomics Firm Sengenics

Oct 14, 2020
|
staff reporter

NEW YORK – Scandinavian private equity firm Summa Equity said Wednesday that it has acquired functional proteomics firm Sengenics.

Founded in 2008, Sengenics produces full-length folded protein arrays using its KREX protein folding technology. Currently, the company is focused on using the technology to discover autoantibody signatures that could be useful for detecting and managing autoimmune and infectious diseases and cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.